Sumner Michael John reported INO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001936799-26-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

May 20, 2026

Published

May 21, 2026

Ingested by INSIDER

Nov 5, 03:57 UTC

Last re-read

Nov 5, 03:57 UTC

Extracted facts

Filer

Sumner Michael John

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

INOVIO PHARMACEUTICALS, INC. — Restricted Stock Unit

Ticker

INO

Shares

37.7K

Price per share

$0

Execution date (reported)

May 20, 2026

Owned after transaction

37.7K shares

Days from execution to publication

1

What this establishes

Sumner Michael John filed this Form 4 reporting a grant or award of INO on May 20, 2026. It became public on May 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Sumner Michael Johncik:0001936799

Issuer

INOVIO PHARMACEUTICALS, INC.cik:0001055726

Revision history · 0

No field has changed since this record was first ingested.